Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evaxion Biotech Q3 EPS $(0.27) Down From $(0.26) YoY

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.27) per share. This is a 3.85 percent decrease over losses of $(0.26) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.27) per share. This is a 3.85 percent decrease over losses of $(0.26) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Genocea Biosciences Earnings Preview

By Benzinga Insights
Today, 6:33 AM
Genocea Biosciences (NASDAQ:GNCA) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Genocea Biosciences will report an earnings per share (EPS) of $-0.20.

GNCA